Sigilon Therapeutics, Inc.·4

Apr 4, 4:50 PM ET

Yuan Qing Sarah 4

4 · Sigilon Therapeutics, Inc. · Filed Apr 4, 2022

Insider Transaction Report

Form 4
Period: 2022-04-01
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-04-01+120,000120,000 total
    Exercise: $1.48Exp: 2032-03-06Common Stock (120,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 25% of the underlying shares of common stock on March 7, 2023, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each quarter following such date until the option is fully vested.

Documents

1 file
  • 4
    form4-04042022_040402.xmlPrimary